Recurrence rate of breast cancer and hormone preparations subcutaneous (goserelin) can be reduced

Breast cancer has become the first women in the top ten cancer, an average of 19 people with breast cancer. Traditional pre-menopausal breast cancer patients will be given after tamoxifen anti-hormone therapy to reduce breast cancer recurrence rate. The latest study found that if the patients without the use of tamoxifen, such as the phenomenon of hot flashes that the poor efficacy of the proposed formulations with subcutaneous hormone (goserelin), in order to increase the rate of breast cancer control, to avoid tumor recurrence. 

 National Cheng Kung University breast surgeon Dr. Tsai-Wang pointed out that in the treatment of breast cancer, the anti-hormone therapy of estrogen receptor-positive is very important in patients with postoperative adjuvant therapy. For pre-menopausal breast cancer patients, the medical community over the years has been the use of tamoxifen as a major anti-hormone therapy drugs, the delay for patients with early breast cancer recurrence and metastasis of breast cancer the opportunity; for advanced disease and metastasis of breast cancer suffering can be achieved to reduce the deterioration of the tumor and alleviate the effects of breast cancer for many years with proven experience in the use of a percent lower mortality rate. 

 Dr. Tsai-Wang pointed out that although the efficacy of tamoxifen has its own, but many patients with a long time because of their hot flashes caused much distress and other side effects, some people even want to stop there. However, according to at American Society of Clinical Oncology December and well-known in the Lancet journal published research has shown that taking tamoxifen have hot flashes phenomenon that drugs be effective, and this has become the treatment of breast cancer important drug reference. 

 Choi Chang-wang said that the medical community understand the indicators, the use of tamoxifen for the poor efficacy of the proposed merger of subcutaneous hormone preparations at the same time (goserelin) use, facilities play a month, allowing dormant ovaries, patients with lower hormone concentration, help control the tumor cells. According to clinical trials confirmed that agents with subcutaneous hormone (goserelin) can reduce the recurrence rate of one percent. The most important thing is, once about two years after the end of treatment, ovarian function can return to normal. 

 Choi Chang-wang said that the breast cancer three years and seven years after the peak period of recurrence of breast cancer, it is proposed to be immediately after the use of anti-hormone therapy to strengthen the control, to avoid the recurrence of breast cancer; At the same time, studies have found that the use of tamoxifen are hot flashes response of the human body is more related enzyme activation, the current medical community has been a key gene can be detected CYD2D6, if the enzyme does not belong to the early activation of those agents with subcutaneous hormone (goserelin), in order to grasp the timing of optimal treatment. 

 In addition, there is thrombosis due to tamoxifen, endometrial thickening, fatty liver, such as side effects, so for endometrial cancer, the risk of thrombosis and abnormal liver function can also use the subcutaneous hormonal agents (goserelin) in lieu of tamoxifen treatment.

The two major breast cancer misconceptions

For the two major misconceptions of breast cancer -- 

 (1) that the young will not get breast cancer; 

 (2) small chest that would not have breast cancer. 

 In addition, according to statistics and research, there are habits countries and regions, the incidence of breast cancer and the recurrence rate is less than or of the countries and regions much higher than that. 

habits it is countries such as Taiwan, Malaysia, Singapore, Hong Kong and other countries the incidence and recurrence of breast cancer (including breast and some of the lesions) than in Europe and the United States much higher, because instant noodles body itself contains a lot of the elements lead to the occurrence of breast cancer. 

 Do not instant noodles body surface and in the production process, in fact, instant noodles have the body surface of the oil contains a lot of material and chemical substances. 

 I have a friend at the instant the company to go to work, his colleagues in the production department had done an experiment on him to let him know of them in fact, instant noodles contain a lot of oily substances, the weight of a full mug so much! (Of course, depending on the brand, the amount of oily material will be different, but the number of poor will not.) And many of these oily substances and chemicals, it is a result of breast lesions and the occurrence of the biggest causes of breast cancer! 

 So, starting today, it is best to quit and some contain preservatives and other chemicals in food.

Young high-grade breast cancer early detection the survival benefit

The "leaves" of a famous singer, "Asan", died yesterday morning due to breast cancer, a 34-year-old year, it is too hush sob, to remind physicians, the study found that young breast cancer some higher grade, easy to relapse, calling young women, do not overlook health check self-censorship and the importance of early diagnosis and treatment of early detection, breast cancer survival rate is quite high. (Xu Yun Xiang reports) 

 According to statistics, the East race, including Taiwan, Singapore, Hong Kong and other countries, the peak age of onset of breast cancer compared with European and American young age, often can be seen clinically young women with breast cancer cases, in addition, some surveys also found that young women think they do not may be young, breast cancer, or more conservative, they neglect to check, resulting in the detection, the breast cancer may have been relatively late. 

 Professor of Surgery at National Taiwan University Hospital, Breast Cancer Prevention Foundation, King-Jen Chang said that the women in addition to self-examination, the importance of regular medical checks, especially in some research found that most of the younger breast cancer patients, if it is negative for hormone receptors, epidermal growth factor is not the performance or over-performance, higher grade, more rapid course of evolution or the metastasis and recurrence, if uncovered as soon as possible, and help enhance the survival rate, "Comparison of a young man, you can check through the breast ultrasound examination, age Great point, after 50 years of age, mammography acceptable, can be found relatively early stage of breast cancer cells can not touch. " 

 King-Jen Chang stressed that if the early treatment of breast cancer, in many cancers is a very good prognosis of cancer, such as clinical, some are teens, more than 20-year-old female breast cancer, because early detection, coupled with treatment, After breast cancer, but also get married and have children, family case successfully called Women Do not overlook the importance of screening by, especially those with a family history of the women, but also to be more vigilant.

Recurrence rate of breast cancer and hormone subcutaneous formulations (goserelin) can be reduced

Breast cancer has become the first female top ten cancer, with an average 19 people every day there is breast cancer. Tradition of pre-menopausal breast cancer patients will be given after tamoxifen anti-hormone therapy to reduce breast cancer recurrence rate. The latest study found that if the use of tamoxifen in patients with no hot flashes, etc. that the effect of poor situation, the proposed formulations with subcutaneous hormone (goserelin), in order to increase breast cancer control rate, to avoid tumor recurrence. 

 National Cheng Kung University breast surgeon Dr. Chang Choi Wang pointed out that in the treatment of breast cancer, the anti-hormone therapy of estrogen receptor positive are very important in patients with postoperative adjuvant therapy. For pre-menopausal breast cancer patients, the medical community over the years has continued to use tamoxifen as a major anti-hormone therapy drug, and its delay for early breast cancer recurrence and metastasis of breast cancer opportunities; for advanced disease and metastasis of breast cancer suffering can be achieved to narrow the breast tumor and alleviate the effects of the deterioration of many years experience in the use of confirmed into one can reduce the mortality. 

 Dr. Tsai-wang pointed out that although tamoxifen has its effect, but has long been a lot of patients because of their hot flashes caused by side effects such as disturbed about, or even someone want to stop there. However, according to at American Society of Clinical Oncology and at December journal Lancet published a well-known studies have shown that taking tamoxifen hot flashes have a situation that has to play the efficacy of the drug, which has also become a breast cancer treatment essential drugs at the time of reference. 

 Choi Chang-wang said that the medical community know the target for the bad effect of the use of tamoxifen, and the proposed merger at the same time subcutaneous hormone preparations (goserelin) the use of injections once a month, allowing access to dormant ovarian status, lower in patients with hormone concentration, help to control tumor cells. According to clinical trials confirmed that agents with subcutaneous hormone (goserelin) can reduce the relapse rate into one. Above all, once about two years after the end of treatment, ovarian function can also return to normal. 

 Choi Chang-wang said that breast cancer after three years and seven years are the peak period of recurrence of breast cancer, so I propose that it should be immediately after the use of anti-hormone therapy in order to strengthen controls to prevent recurrence of breast cancer; simultaneously study also found that the use of tamoxifen have hot flushes reaction of the body express the relevant enzyme is more activated, the current medical community has been a key gene can be detected CYD2D6, if the enzyme does not belong to the early activation of those agents with subcutaneous hormone (goserelin), in order to grasp the best treatment time. 

 In addition, tamoxifen because there is thrombosis, endometrial thickening, fatty liver, such as side effects, so for endometrial cancer, thrombosis risk as well as abnormal liver function can also use the subcutaneous hormonal agents (goserelin) in lieu of tamoxifen treatment.

No longer lonely

April 2003, I find myself on the left breast has a lump, after diagnosis of malignant tumors to identify. At that time, the hearts of great fear, unaccompanied in a foreign country, lonely and helpless, do not know how to deal with cancer the impact on my life, coupled with the language barrier, there is no insurance, and economic constraints, is really worse, I have the collapse of the whole person a. Tears wash day, I do not know what to do, in fear and despair I am disappointed, I came to the angle the sound Cancer Society, it was a small reception me, and I quickly arranged the interview with Mrs. Yang. She over the identity of a cordial talk with me, gave me a lot of encouragement and so I have a correct understanding of breast cancer and reduce my fear and fear, but also encouraged me to take part in cancer is being organized by Friends of picnickers. In that outing, the Friends have seen many cancer optimistic face of disease, but also gave me great confidence, so that I can see a glimmer of hope. 

The absence of medical insurance, surgical delay can not be, in my anxious wait, the angle of the president of the Cancer Society sound-hi, FU Yao, physicians, a clear analysis of pathology reports to help me and give many of the proposals and instructions, Miss enthusiastic positive sister helped me to apply for Medicaid, in a hot afternoon, she and small to give up lunch time, personally took me to the relevant departments to drive the implementation of 11, followed by her phone up every day? the progress of my application, after Cancer Society Kok sound assistance and persistent efforts, the Government's medical subsidy will soon be awarded down. In surgery and treatment, Kok sound and sisters gave me unlimited love, care and encouragement, especially in those days of chemotherapy, the Friends will take part in cancer's "what treatment," is my pillar of the spirit, I am in love courageous to come out. 

However, Thanksgiving is most worthy of their lead I really know God. C. Sound Cancer Society staff and volunteers often pray for me, with me in tears and told me all worried about the burden of all to God, let God to take charge of everything, so I body, mind, and spirit to be God's completely heal. I deeply thank them for their delicate love, give me new hope, so I became a Christian, have a hope of eternal life, so every day I have peace, joy, life in the future also have a new start. For all this, I want to thank all, are the property of praise and glory to love my God, let me in the pain experienced His love and grace. I would like to become a future flow of the pipeline, must be God's love, Kok acoustic love Cancer Society, the spread of spread it out and have to take the initiative to care about and help those in need.

Breast cancer-related web pages

American Cancer Society 
• www.cancer.org 
• 1-800-ACS-2345 (1-800-227-2345) - 24-hour hotline 

Breast Cancer.Org 
• http://www.breastcancer.org 

Cancer Treatment Centers of America 
• www.cancercenter.com 
• 1-800-515-1214 

Inflammatory Breast Cancer 
• http://www.ibchelp.org 

Living Beyond Breast Cancer 
• http://www.lbbc.org 
• I-888-753-5222 

National Lymphedema Network 
• http://www.lymphnet.org 
• 1-800-541-3259 

Susan G. Komen Race for the Cure 
• www.komen.org 
• 1-800-462-9273 

The Wellness Community 
• www.thewellnesscommunity.org 
• 1-888-793-9355 

Y-Me National Breast Cancer Organization 
• www.y-me.org 
• 1-800-221-2141 - 24-hour hotline

Breast cancer, cervical cancer screening inquiries, please call

Nation states for low-income people to provide free breast and cervical cancer screening inquiries, please call 
(States of different eligibility criteria, please call your State of residence of the plan the implementation of departmental liaison)

Alabama 
Breast and Cervical Cancer Early Detection Program*
(334) 206-5851

Alaska 
Breast and Cervical Health Check*
(907) 269-3491

American Samoa 
Breast and Cervical Cancer Early Detection Program
(684) 633-2135

Arizona 
Well Woman Healthcheck Program*
(888) 257-8502

Arkansas
BreastCare Program*
(501) 661-2000

California 
Cancer Detection Programs: Every Woman Counts*
(916) 449-5300

Colorado 
Women’s Wellness Connection*
(303) 692-2581

Commonwealth of Northern Mariana Islands
Breast and Cervical Cancer Screening Program
(670) 236-8703

Connecticut 
Breast and Cervical Cancer Program*
(860) 509-8309

Delaware 
Screening for Life*
(302) 744-1040

District of Columbia 
Breast and Cervical Cancer Early Detection Program*
(202) 442-5900

Florida 
Breast and Cervical Cancer Early Detection Program*
(850) 245-4444

Georgia 
Breast and Cervical Cancer Program*
(404) 657-6611

Guam 
Breast and Cervical Cancer Early Detection Program
(671) 735-7174
Fax: (671) 735-7103

Hawaii 
Hawaii Breast and Cervical Cancer Program*
(808) 586-4609

Idaho 
Women's Health Check*
(208) 332-7311

Illinois 
Illinois Breast and Cervical Cancer Program*
(217) 785-1050

Indiana 
Breast and Cervical Cancer Early Detection Program*
(317) 234-1356
(800) 433-0746

Iowa 
Care for Yourself*
(515) 242-6067

Kansas 
Early Detection Works*
(785) 296-1207

Kentucky 
Kentucky Women's Cancer Screening Program*
(502) 564-2154

Louisiana 
Louisiana Breast and Cervical Health Program*
(888) 599-1073

Maine 
Breast and Cervical Health Program*
(207) 287-8068

Maryland 
Breast and Cervical Cancer Screening Program*
1 (800) 477-9774

Massachusetts 
Women’s Health Network*
(617) 624-5434

Michigan 
Breast and Cervical Cancer Control Program*
(517) 335-8049

Minnesota 
SAGE Screening Program*
(651) 201-5618

Mississippi 
Mississippi Breast and Cervical Cancer Early Detection Program*
(601) 576-7466

Missouri 
Show Me Healthy Women Program*
(573) 522-2845

Montana 
Breast and Cervical Health Program*
(406) 444-0063

Nebraska 
Every Woman Matters Program*
(402) 471-0314

Nevada 
Women's Health Connection*
(775) 684-5926

New Hampshire 
Breast and Cervical Cancer Program*
(603) 271-4886

New Jersey 
Cancer Education and Early Detection Program*
(609) 292-8540

New Mexico 
Breast and Cervical Cancer Early Detection Program*
(505) 841-5860

New York 
Cancer Services Program*
(518) 474-1222

North Carolina 
Breast and Cervical Cancer Control Program*
(919) 707-5300

North Dakota 
Women's Way Program
(701) 328-2472

Ohio 
Breast and Cervical Cancer Project*
(614) 466-2144

Oklahoma 
Breast and Cervical Cancer Early Detection Program*
(405) 271-4072

Oregon 
Breast and Cervical Cancer Program*
(971) 673-0581

Pennsylvania 
Breast and Cervical Cancer Early Detection Program*
(717) 783-1457

Puerto Rico 
Breast and Cervical Cancer Early Detection Program
(787) 772-8300 ext 232

Rhode Island 
Women's Cancer Screening Program*
(401) 222-1161

South Carolina 
Breast and Cervical Cancer Early Detection Program
(803) 545-4145

South Dakota 
All Women Count!*
(605) 773-5728

Tennessee 
Breast and Cervical Cancer Early Detection Program
(877) 969- 6636

Texas 
Breast and Cervical Cancer Control Program*
(512) 458-7796

Utah 
Utah Cancer Control Program*
(801) 538-6141

Vermont 
Ladies First*
(802) 863-7331

Virginia 
Breast and Cervical Cancer Early Detection Program*
(804) 864-7761

Washington 
Washington Breast and Cervical Health Program*
(360) 236-3672

West Virginia 
Breast and Cervical Cancer Screening Program*
(304) 558-7180

Wisconsin 
Well Woman Program*
(608) 261-6872

Wyoming 
Breast and Cervical Cancer Early Detection Program
(307) 777-6006

Cherokee Nation 
Cherokee Nation*
(918) 458-4491

Cheyenne River Sioux Tribe 
Cheyenne River Sioux Tribe*
(605) 964-8917

Hopi Tribe
Breast and Cervical Cancer Early Detection Program
(928) 734-1150

Kaw Nation of Oklahoma 
Kaw Nation Programs and Services*
(580) 362-1039 Ext. 228

Navajo Nation 
Breast and Cervical Cancer Early Detection Program
(928) 871-6249 Ext. 23

South East Alaska Regional Health Consortium 
South East Alaska Regional Health Consortium
(888) 388-8782

South Puget Intertribal Planning Agency Breast and Cervical Cancer Early Detection Program
(360) 426-3990

Southcentral Foundation 
Breast and Cervical Cancer Early Detection Program
(907) 729-8891

Yukon-Kuskokwim Health Corporation
Breast and Cervical Cancer Early Detection Program
(907) 543-6996

Early intake of vitamin D can reduce the incidence of breast cancer

Vitamin D with the relationship between breast cancer incidence has not yet a very good conclusion, Toronto, Canada, Mount Sinai Hospital Dr. Blackmore's study found that if vitamin intake during adolescence, when D, often with the sun or eat more vitamin D food can reduce the incidence of breast cancer. 

Research is a 759 breast cancer patients and 1135 healthy women to do the control group, by telephone interviews and analyzed their diet, vitamin D added that the sun and the extent of the relationship with breast cancer. He put these cases are divided into 10-year-old to 19 years old, 20-29 years and 45-54 years old, such as three groups of different age groups to explore. In 759 breast cancer patients, with hormone receptor to be divided into three groups: ER + / PR + 450 (59%); ER + / PR-110 (14%); ER-/PR- there are 199 (26%), etc. The results showed that the amount of intake of vitamin D and breast cancer hormone receptor different groups did not have any relevant, but found 10-year-old to 19-year-old intake of cod liver oil for ER + / PR + breast cancer can be reduced 24%, ER + / PR-and ER-/PR- is also able to reduce 21% ~ 26%. 

Blackmore also stressed in the previous medical report points out that taking cod liver oil and breast cancer, there is no correlation between the occurrence may be noted that did not really start taking cod liver oil age. Therefore, according to Blackmore study concluded that vitamin D from a young age on the incidence of breast cancer is influential.

What people tend to get breast cancer?

1. Early as early as 12 years of age, menopause later than 55-year-old woman. 
2. There are breast cancer patients of the family, particularly his mother or sister who suffered from the disease. 
3. Never childbirth or after 30-year-old first child, who also have a greater potential cancer.
4. From the side of breast cancer. 
5. Breasts proliferative lesions were. 
6. Ovarian cancer and endometrial cancer patients. 
7. Obese post-menopausal. 
8. Chest has a large number of those who received radiation. 
9. Persons with severe alcohol. 
10. Intake of high fat, high-calorie food of women. 
11. Oral contraceptives and post-menopausal hormones were added.

Bone metastasis of breast cancer treatment or to use Zometa, Zometa is superior because Aredia

Article 4 of breast cancer patients often a result of bone metastasis and bone pain symptoms, but also prone to fractures, in the lumbar spine, thoracic fracture, etc. will be nerve compression caused by lower limb paralysis, urinary incontinence and so on, so to prevent bone metastasis of breast cancer complications arising out of survival for a longer period of breast cancer is a very important task. 
Two-phosphate-type drugs can indeed reduce the complications of bone metastases, there are second-generation Aredia and third generations of Zometa, for breast cancer patients, the third-generation drug Zometa than the second generation of Aredia is good? Los Angeles medical research team of Dr. Luo Sen cancer research team that Zometa is indeed better than a good Aredia. Study group is to have a 1130 breast cancer patients with bone metastases, Zometa and Aredia is divided into two groups; Zometa this group is divided into 4 mg and 8 mg dose to make analysis of the use of comparison, the long-term follow-up to analyze the three treatment plans, to see which group is more effective prevention of skeletal complications. The three groups of about 44% of patients do have bone-related complications; the results of the analysis is Zometa to prevent bone-related complications such as fractures, spinal compression effect even better than Aredia, but the size of dose and efficacy of unrelated, but the side effects of low-dose less than high dose. 
Concluded that the prevention of bone metastases for the effectiveness of third-generation better than the second generation, but so far such treatment does not extend the lives of patients, but it can reduce complications after bone metastases, which can really improve the quality of life of patients .

He Zhuo bone (Zometa) can be effective in preventing pre-menopausal breast cancer patients because they have received adjuvant hormonal therapy for bo

Breast cancer patients receiving postoperative adjuvant therapy, the treatment often causes bone loss caused by complications of bone. And supporting menopausal hormone replacement therapy for breast cancer patients before, is often important after chemotherapy treatment, one study shows that the longer the use of hormone therapy, bone density decrease in more serious cases. Every six months if they can give him bone zhuo 4-8 mg, with the rules of bone mineral density tracking, would be effective in the prevention of hormone therapy due to bone loss caused by.

Age-related, hormone receptor-positive are of locally advanced breast cancer before surgery can choose to use hormone replacement therapy

Recently, there have been spaces for senior citizens over 70-year-old woman, because of breast cancer tumor is too large and can not be immediate surgery, coupled with past stroke lead to mobility, such a past, we will take pre-operative chemotherapy, so that tumor shrinkage after surgery. But the elderly are often associated with other major diseases, so to carry out pre-operative chemotherapy, it is bound to have a high chance of serious complications. 
This is the elderly in 2007 of breast cancer treatment to reach a new consensus. At present, hormone replacement therapy as a result of advances make it possible for this situation can be the use of hormone therapy to control local tumor and the tumor is reduced, and thus an opportunity for less invasive surgery; this will risk than other therapies to small Multi. 
  
Over the past can be used in hormone replacement therapy is the drug Tamoxifen, but resistance is likely to have its shortcomings. A new generation of hormone replacement therapy drugs - aromatase inhibitors transformation (AI) is the better choice.

Magnetic resonance imaging (MRI) has been newly diagnosed breast cancer patients to assess their situation in the role of contralateral breast

This is an article published in New England Journal of Medicine by the end of March 2007 summary of the article. 
Based on past research, for the recently diagnosed breast cancer patients, the other side of the probability of breast cancer is as high as 10 percent, so check to see if magnetic resonance imaging has its role, is worthy of observation. 
The results showed: MRI was on the other side of breast cancer detection sensitivity of up to 9-cheng, specificity is also nearly 9-cheng, and the negative predictive rate is closer to 100 percent. 
Therefore, for the MRI mammography and clinical examination of the other side of impossible to find out whether the breast cancer also is very helpful.

Her-2/neu positive for the treatment of locally advanced breast cancer chemotherapy leading prescription alternative

The study research team in the United States in April 2007 in the "Journal of Clinical Oncology" published. 
Their section 2B, and 3 and of Her-2/neu positive locally advanced breast cancer, given every two weeks for a course of Taxol in Europe, to eliminate cancer-ping (docetaxel 60 mg/m2, vinorelbine 45 mg/m2) plus He's cancer-ping, a total of 3 months. Before surgery, a pre-assessment of the clinical effectiveness of chemotherapy prescription. 
The results showed that this prescription, leading to clinical complete response rate (cCR) 94%, pathological complete response rate (pCR) to 39 percent, although the clinical effectiveness of good, but be careful of this prescription a substantial proportion of white blood cells to reduce the situation.

The surgery can be easier to deal with the future recurrence of breast cancer in high-risk groups, in the end after receiving intensive chemotherapy d

The surgery can be easier to deal with the future recurrence of breast cancer in high-risk groups, postoperative adjuvant therapy should be taken to reduce the recurrence of what manner? Is taken to contain the epidemic now anthracycline and taxane dose-intensive chemotherapy, or should be used first to anthracycline-based chemotherapy to continue the high-dose chemotherapy combined with autologous stem cell transplant? 
 
Recently, the problem in the United States S9623 research reply. 
 
The results showed that, no matter in what manner, and its disease-free survival and overall survival time were fairly consistent, but the toxicity of high-dose chemotherapy is more special attention.

Blood phytoestrogen content will affect the future risk of developing breast cancer

Phytoestrogen is fever over the past few years is the topic, of which the most notable of soybean isoflavone. Major components of soy isoflavone are genistein, daidzein, these compounds have antioxidant properties, they are able to prevent cancer. Soy isoflavone genistein on the principal components can inhibit cell proliferation and cell differentiation, and inhibit the effect of the increase with dose. . Because genistein is an effective inhibitor of tyrosine kinase. genistein can inhibit DNA topoisomerase (DNA topoisomerases) Ⅰ and Ⅱ and its signal transduction important enzymes, so-like isoflavones in cancer prevention plays an important role. 
  
Such phytoestrogen its structure and function in terms of both estrogen and human is very similar. In theory, this type of plant estrogen and estrogen also by competing with the in vivo estrogen receptor binding manner, making phytoestrogen had diminished as a result of female hormones to stimulate the body, thereby reducing the risk of breast cancer . 
  
In fact really true? British research team carried out against this assumption, and a large-scale prospective study, and the results of the study published in February 2007 the well-known magazine - "Journal of Clinical Oncology." 
  
They monitored 383 women have been suffering from breast cancer (including pre-and post-menopause) the blood concentration of plant estrogen, and the corresponding 383 women compared to normal. It was found that genistein at high concentrations in blood, their breast cancer risk will be reduced. And phytoestrogens in lignans (Lignan) the level of its value, not in any way. 
Great credibility from this study, we is not hard to see, plant estrogen for breast cancer prevention is of great potential.

For Herceptin in the treatment of failure of those new hope: lapatinib (Tykerb)

A breast cancer drug lapatinib (Tykerb, by GlaxoSmithKline pharmaceutical manufacturers) When used with capecitabine (Xeloda, Roche pharmaceutical manufacturers) and for receiving trastuzumab (Herceptin cancer Ping He, Genentech / Roche pharmaceutical manufacturers) in the treatment of the failure of HER2 receptor positive women's breast cancer, the use of lapatinib will be able to extend the time for patients whose condition had deteriorated to Tatsu 2 times. 
  
The trial results are published in the December 28, 2006 --- the best medical journal New England Journal of Medicine, the trial received a 324 belonging to He Ping cancer treatment failure of the HER2 receptor positive breast cancer patients, the initial Research results have been published in the 2006 American Society of Clinical Oncology annual meeting, due to very positive results, the independent data monitoring committee early termination of the vendor-sponsored tests. 

U.S. Food and Drug Administration (FDA) in March 2007 end of the breast cancer drug Tykerb approved the listing of the end of suffering from malignant breast cancer, other treatments can not be suppressed to provide a new choice for women. 
  
HER2 overexpression for the suffering of patients with advanced or metastatic breast cancer, He Ping is already the standard of cancer treatment, the current proposal is He Ping cancer with chemotherapy. However, epithelial growth factor receptor (EGFR) over-performance of the treatment of patients with breast cancer associated with poor prognosis, but also, and He Ping cancer treatment failure very well. Therefore, overexpression of the HER2 receptor positive cells, at the same time inhibit EGFR and HER2, is additive effect. Lapatinib is an oral tyrosine kinase inhibitors, is a kind of role can be in the EGFR and HER2. 17.5% of patients taking lapatinib will happen a third-class diarrhea. Other third-tier side effects include skin rashes, fatigue 
, Nausea, anorexia, vomiting, but the incidence of less than 10%.

With regard to breast lumps, do not think that is breast cancer

90 percent of breast lumps or pain is not breast cancer 
Breast cancer, breast lumps is the most important clinical presentation, although the majority of breast tumors are benign, but the touch should consult any breast tumor of the breast tumor-associated physicians to distinguish benign or malignant tumors of their belonging. A variety of related diseases of breast lumps its symptoms as follows: 
Fibrous cyst: 
This is the most common benign breast lumps, was particularly prevalent in the 30-year-old women, are often multiple and bilateral  and bulging pain tenderness. To pre-menstrual symptoms of the most formidable, and the masses will become large. The patient is suddenly got this lump, and feel like a fluid-filled balloons, and tenderness, the outline of a clear, micro-moving to a flashlight according to the breast area will be translucent. Such as needle extraction, may have not included a turbid blood, yellow or brown liquid, if the cyst is located in the depths of the breast, it may touch the masses like cancer. 
Fibroadenoma: 
20-year-old women most. Tumor will be mobile, substantive, such as rubber-like hardware, edge neatly, no tenderness nor pain. 
Papillomas tube: 
40-year-old women are more often unilateral occurred suddenly nipple yellow, pink liquid from water samples at this time do not feel pain less than a mass, usually it is a larger duct epithelial hyperplasia due. 
Duct Expansion (acne of mastitis): 
Found in more than 40-year-old women, nipple discharge and less changeable color thick liquid. On both sides of the occurrence and spread to several duct, patients have burning, itching or areola feel pain, palpation will be found under the areola enlargement of curved duct. If exacerbations, mass appears, from the appearance is like the third phase of breast cancer, and breast inflammation plasma cells. 
Gynecomastia: 
Before or during adolescence, when adolescent boys, in the unilateral areola will happen on a hard and painful mass round, will become large or swelling, so that the same side of the breast and the pain increased. 
Breast cancer: 
Unilateral breast often have a hard substantive, non-mobile, not pain and irregular contour of the mass, was particularly prevalent in the top of the lateral breast. With the cancer violations, and other symptoms have emerged one after another: If axillary lymph nodes hardened, nipple-like subsidence or blood secretions, breast skin, such as citrus peel. Not all breast cancer will have the above symptoms, some only a nipple eczema, skin irritation, subcutaneous infiltration or feels can be moved, not hard mass.